Log in
NASDAQ:RELV

Reliv' International Stock Forecast, Price & News

$3.72
+0.02 (+0.54 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.70
Now: $3.72
$3.73
50-Day Range
$3.35
MA: $3.64
$3.94
52-Week Range
$2.60
Now: $3.72
$7.75
Volume8,224 shs
Average Volume19,837 shs
Market Capitalization$6.50 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.1
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
Current SymbolNASDAQ:RELV
CUSIPN/A
Phone636-537-9715
Employees91

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$35.06 million
Cash Flow$0.08 per share
Book Value$6.36 per share

Profitability

Net Income$-440,000.00

Miscellaneous

Market Cap$6.50 million
Next Earnings Date3/26/2021 (Estimated)
OptionableNot Optionable
$3.72
+0.02 (+0.54 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Reliv' International (NASDAQ:RELV) Frequently Asked Questions

How has Reliv' International's stock price been impacted by COVID-19?

Reliv' International's stock was trading at $3.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RELV shares have increased by 14.5% and is now trading at $3.72.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Reliv' International?

Wall Street analysts have given Reliv' International a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Reliv' International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Reliv' International's next earnings date?

Reliv' International is scheduled to release its next quarterly earnings announcement on Friday, March 26th 2021.
View our earnings forecast for Reliv' International
.

How were Reliv' International's earnings last quarter?

Reliv' International, Inc. (NASDAQ:RELV) issued its earnings results on Friday, May, 15th. The company reported $0.38 earnings per share (EPS) for the quarter. The company earned $10.28 million during the quarter. Reliv' International had a negative net margin of 0.61% and a negative return on equity of 1.89%.
View Reliv' International's earnings history
.

Are investors shorting Reliv' International?

Reliv' International saw a decline in short interest in October. As of October 30th, there was short interest totaling 4,700 shares, a decline of 24.2% from the October 15th total of 6,200 shares. Based on an average daily trading volume, of 9,400 shares, the short-interest ratio is presently 0.5 days. Currently, 0.4% of the shares of the stock are sold short.
View Reliv' International's Short Interest
.

Who are some of Reliv' International's key competitors?

What other stocks do shareholders of Reliv' International own?

Who are Reliv' International's key executives?

Reliv' International's management team includes the following people:
  • Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 78, Pay $538.27k)
  • Mr. Ryan A. Montgomery, CEO & Director (Age 46, Pay $218.89k)
  • Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 69, Pay $342.38k)
  • Mr. Steven D. Albright CPA, CPA, Sr. VP & CFO (Age 58)
  • Ms. Debra P. Bernardoni, Sr. VP & COO (Age 49)
  • Mr. Stephen M. Merrick, Gen. Counsel & Sec. (Age 78)
  • Mr. Donald E. Gibbons Jr., Sr. VP of US Sales (Age 65)
  • Mr. R. Scott Montgomery, Pres of Operations & International (Age 50)
  • Mr. Kurt C. Wulff, Sr. VP of Marketing (Age 55)
  • Ms. Susan R. Stone, Managing Director of Reliv Asia Pacific

What is Reliv' International's stock symbol?

Reliv' International trades on the NASDAQ under the ticker symbol "RELV."

How do I buy shares of Reliv' International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Reliv' International's stock price today?

One share of RELV stock can currently be purchased for approximately $3.72.

How big of a company is Reliv' International?

Reliv' International has a market capitalization of $6.50 million and generates $35.06 million in revenue each year. Reliv' International employs 91 workers across the globe.

What is Reliv' International's official website?

The official website for Reliv' International is www.reliv.com.

How can I contact Reliv' International?

Reliv' International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.